Frontiers in Immunology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-10-27 ms4000001836130031 来自吉林省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：综述
经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了

74 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-05-19 14853348m56暂无昵称来自上海

很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。

129 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-10-19 ms6000001878152948 来自黑龙江省

我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。

108 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-05-09 小小小天才大大大梦想来自湖南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：疫苗导致疾病
经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！

133 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-03-06 benmaomaoxiong 来自上海

大家EA分配编辑用了多久啊，投稿1周还是EA中，着急

82 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-03-23 shengjin 来自浙江省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床实用性;肿瘤;免疫治疗
经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …

118 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-06-27 yanglcau 来自河北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：妊娠免疫
经验分享：Received date: 10 May 2023
Editorial assignment start date: 12 May 2023
Independent review start date: 24 May 2023
Review finalized date: 16 Jun 2023
Final validation date: 20 Jun 2023
同日接收。

150 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-10-22 ms4000001204939399 来自广东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：综述
经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2022-05-27 148497e6m10暂无昵称

请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗

152 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2131264, encodeId=67ee2131264f3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疫苗导致疾病 经验分享：今年一月份投稿，二月份编辑送外审，4月份审稿人回复大修，按要求大修10天后审稿人非常爽快的同意发表，一周后主编拒绝，理由是不符合杂志定位，然后给我推荐了另外一个frontiers旗下的杂志，我进去看了一下，我觉得这个杂志才是真不符合，我也是服了，不知道是这位主编水平不行，还是碰到了一个故意刁难中国人的主编，气死！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221119/d3f52e4ff9a245748666f9244263e277/4bd1a57ae46f491cbb6f3c05565f9132.jpeg, createdBy=b5998440121, createdName=小小小天才大大大梦想, createdTime=Tue May 09 23:44:18 CST 2023, time=2023-05-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2117866, encodeId=7ff9211e8668e, content=大家EA分配编辑用了多久啊，投稿1周还是EA中，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cbd873243, createdName=benmaomaoxiong, createdTime=Mon Mar 06 09:02:39 CST 2023, time=2023-03-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121340, encodeId=cced212134020, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床实用性;肿瘤;免疫治疗 经验分享：3.7投稿 3.8分配编辑 3.9送审 3.13-3.15陆续收到4位审稿建议，3位同意接受，1位给出小修 3.18修回快的有点心慌 …, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ffbe1994871, createdName=shengjin, createdTime=Thu Mar 23 13:31:56 CST 2023, time=2023-03-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145122, encodeId=2d58214512244, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：妊娠免疫 经验分享：Received date: 10 May 2023 Editorial assignment start date: 12 May 2023 Independent review start date: 24 May 2023 Review finalized date: 16 Jun 2023 Final validation date: 20 Jun 2023 同日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a73730185, createdName=yanglcau, createdTime=Tue Jun 27 23:31:05 CST 2023, time=2023-06-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2164210, encodeId=dc962164210a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：综述 经验分享：这个杂志有被预警的风险吗？接收了，但是被认为有预警风险，打算撤稿值当吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3185482121, createdName=ms4000001204939399, createdTime=Sun Oct 22 16:31:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222842, encodeId=dedf122284224, content=请问下大家，Review Finalized阶段需要多久啊，我的三个审稿人都给了很少的意见，有一个同意直接发表，但Review Finalized已经8天了没有任何消息，可以催编辑吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930a5283234, createdName=148497e6m10暂无昵称, createdTime=Fri May 27 17:37:14 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129747, encodeId=50c12129e4735, content=请问理由是这份手稿不符合为考虑出版的期刊制定的标准。 评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.” 有人遇到吗？这个可以申诉吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cb28211654, createdName=ms2000001482982187, createdTime=Tue May 02 20:49:44 CST 2023, time=2023-05-02, status=1, ipAttribution=湖北省)]

2023-05-02 ms2000001482982187 来自湖北省

请问理由是这份手稿不符合为考虑出版的期刊制定的标准。
评论里面也是这个意思，还加了句：“This decision applies across all Frontiers journals and is final.”
有人遇到吗？这个可以申诉吗

49 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务